Medication Fact Sheets
|
November 29, 2024

Farxiga: Uses, Side Effects, and Generic Alternatives

Written By
Medically Reviewed by
Updated On
December 4, 2024

Farxiga is a medication often prescribed to help support better blood sugar control in people with certain health conditions. It works in a unique way to help the body remove excess sugar through the urine. While Farxiga can be an effective part of some treatment plans, it’s important to understand how it works, its possible side effects, and alternatives that may be available.

This article will cover what Farxiga is used for, common side effects, and whether a generic version is available. We'll also explore how Farxiga works and how it compares to similar medications.

[signup]

What is Farxiga?

Farxiga is a brand-name medication with the active ingredient dapagliflozin. It belongs to a group of drugs called SGLT2 inhibitors, which stands for sodium-glucose co-transporter-2 inhibitors. These medications are commonly prescribed to help manage Type 2 diabetes, chronic kidney disease (CKD), and heart failure.

Farxiga works by blocking a protein in the kidneys that normally reabsorbs sugar (glucose) back into the bloodstream. Instead, this sugar is removed from the body through urine, which helps lower blood sugar levels in people with diabetes. Additionally, Farxiga has been shown to protect the heart and kidneys in certain patients, making it a versatile treatment option.

Purpose and FDA Approvals

Farxiga was initially approved by the U.S. Food and Drug Administration (FDA) in 2014 for managing Type 2 diabetes. Over time, research revealed its broader benefits for heart and kidney health. This led to additional FDA approvals, including:

  • Chronic Kidney Disease (2021): Farxiga was approved to help slow kidney damage and improve kidney function in people with CKD, regardless of whether they have diabetes.
  • Heart Failure (2020): Farxiga is approved to reduce the risk of hospitalization and improve heart function in patients with certain types of heart failure.

How Farxiga Works: Mechanism and Effectiveness

Farxiga is a brand-name medication with the active ingredient dapagliflozin. It belongs to a group of drugs called SGLT2 inhibitors, which stands for sodium-glucose co-transporter-2 inhibitors. These medications are commonly prescribed to help manage Type 2 diabetes, chronic

Farxiga Side Effects: What Patients Should Know

Farxiga is an effective medication for managing Type 2 diabetes, chronic kidney disease, and heart failure, but like any medication, it can cause side effects. Understanding these potential issues can help patients use Farxiga more safely and effectively.

Common Side Effects

Some of the most common Farxiga side effects are mild and often improve with time. These include:

  • Increased urination: Farxiga causes the body to excrete more glucose through urine, which can lead to frequent trips to the bathroom.
  • Urinary tract infections (UTIs): The extra glucose in the urine may increase the risk of infections in the urinary tract. Symptoms include pain or burning during urination.
  • Yeast infections: Both men and women may experience fungal infections, especially in warm, moist areas of the body.
  • Mild dehydration: Farxiga may lead to slight dehydration due to increased urination, causing symptoms like dry mouth or dizziness.

Severe Side Effects

While rare, some Farxiga side effects can be serious and require immediate attention:

  • Dehydration: Excessive urination may lead to significant fluid loss, causing dizziness, fainting, or low blood pressure.
  • Diabetic ketoacidosis (DKA): This is a life-threatening condition where the body produces harmful levels of ketones. Symptoms include nausea, vomiting, abdominal pain, and confusion.
  • Kidney issues: Farxiga can occasionally lead to kidney problems, especially in patients with pre-existing kidney conditions. Watch for symptoms like reduced urination or swelling in the legs.
  • Genital infections: In rare cases, Farxiga can cause serious infections in the genital area, such as Fournier’s gangrene (a rare but serious bacterial infection).

If you experience any of these symptoms, seek medical attention right away.

Long-Term Risks and Considerations

Clinical studies so far suggest that Farxiga is generally safe for long-term use when taken as prescribed. However, ongoing monitoring is important to detect any kidney function changes or other complications over time. 

Patients with a history of recurrent infections or dehydration should discuss these risks with their doctor.

Best Practices for Managing Side Effects

To minimize Farxiga side effects, consider the following tips:

  • Stay hydrated
  • Practice good hygiene to help prevent UTIs and yeast infections.
  • Monitor blood sugar and ketones
  • Consider lifestyle adjustments.
  • Always inform your healthcare provider about any new or worsening side effects.

Farxiga vs. Generic Alternatives

As of now, a generic version of Farxiga (dapagliflozin) is not widely available. The availability of generics often depends on the expiration of patent protections for the brand-name drug. Farxiga’s patent is still in effect in many regions, limiting the ability of other manufacturers to produce a lower-cost generic alternative.

Once the patent expires, generic versions may be approved by regulatory agencies like the FDA if they meet strict safety and efficacy standards. These generics would contain the same active ingredient, dapagliflozin, and work in the same way as the brand-name medication.

Cost Comparison: Brand-Name Farxiga vs. Generic Options

Without a generic alternative, brand-name Farxiga remains one of the more expensive medications for managing diabetes, kidney disease, or heart failure. Prices can vary by pharmacy, insurance coverage, and location, but a typical monthly supply may cost several hundred dollars without insurance.

Once generic versions become available, prices are expected to drop significantly. Generics are often 20–80% cheaper than brand-name drugs, offering substantial savings for patients. For example, other SGLT2 inhibitors like empagliflozin (brand name Jardiance) may have generics available sooner, which could provide a more affordable alternative.

Pros and Cons of Generic Medications for Patients

Here are some benefits of generic medications:

  1. Cost Savings: Generic medications are typically much more affordable, making them accessible to a wider range of patients.
  2. Similar Efficacy: The FDA requires generics to have the same active ingredient, dosage, and effectiveness as the brand-name drug.
  3. Insurance Coverage: Many insurance plans are more likely to cover generics or offer lower copays compared to brand-name drugs.

Here are potential limitations of generic medications:

  • Inactive Ingredients: While the active ingredient is the same, the fillers or inactive ingredients may differ, which could affect people with allergies or sensitivities.
  • Perception of Quality: Some patients may feel that generics are less effective, although clinical evidence does not support this.
  • Availability Delays: It can take time for generics to reach pharmacies after patents expire.

Usage Guidelines: Dosage and Administration

The typical dosage of Farxiga depends on the condition being treated. Always follow your doctor’s specific instructions, as individual needs may vary.

  • Type 2 Diabetes: The standard dose is 5 mg once daily, which may be increased to 10 mg daily if additional blood sugar control is needed.
  • Heart Failure: The usual dose is 10 mg once daily to reduce the risk of hospitalization and improve heart function.
  • Chronic Kidney Disease (CKD): The recommended dose is 10 mg once daily to slow the progression of kidney damage and improve kidney function.

Administration Tips and Timing

  • With or Without Meals: Farxiga can be taken with or without food, making it convenient for patients to fit into their daily routine.
  • Daily Timing: Take Farxiga at the same time each day to help maintain consistent levels of the medication in your body. Morning is often preferred due to the increased urination it may cause.
  • Storage: Store Farxiga at room temperature, away from moisture and heat. Keep the medication in its original packaging until use.

Missed Dose & Overdose Protocols

  • Missed Dose: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.
  • Overdose: If you accidentally take too much Farxiga, contact your doctor or seek emergency medical help immediately. Symptoms of overdose may include extreme dehydration, dizziness, or low blood sugar. Drink plenty of fluids (unless your doctor advises otherwise) and monitor for any unusual symptoms.

Interactions and Contraindications

Certain medications and supplements can interact with Farxiga, potentially reducing its effectiveness or increasing the risk of side effects. Here are some common drug interactions to watch for:

  • Diuretics (water pills): These medications, like furosemide or hydrochlorothiazide, can increase the risk of dehydration when combined with Farxiga.
  • Insulin or insulin secretagogues: Combining Farxiga with insulin or medications like sulfonylureas may increase the risk of low blood sugar (hypoglycemia).
  • Antihypertensive drugs: Medications used to lower blood pressure, such as ACE inhibitors or ARBs, may amplify the blood-pressure-lowering effects of Farxiga, causing dizziness or fainting.
  • NSAIDs (e.g., ibuprofen): These may affect kidney function when taken with Farxiga, especially in patients with underlying kidney issues.

Always inform your doctor about all medications, supplements, or herbal products you are taking before starting Farxiga.

Contraindications

Farxiga is not suitable for everyone. It is contraindicated in the following situations:

  • Type 1 Diabetes: Farxiga is not approved for treating Type 1 diabetes due to the risk of diabetic ketoacidosis (DKA).
  • Severe Kidney Disease: Patients with advanced kidney disease or those on dialysis should not take Farxiga.
  • Pregnancy and Breastfeeding: Farxiga is not recommended during pregnancy or while breastfeeding, as its effects on fetal development and infants are not fully understood.
  • Allergy to Dapagliflozin: Anyone allergic to the active ingredient or other components of Farxiga should avoid this medication.

Frequently Asked Questions (FAQs) About Farxiga

Here are frequently asked questions and answers about Farxiga

What is Farxiga used for?

Farxiga is used to manage Type 2 diabetes, chronic kidney disease (CKD), and certain types of heart failure. It helps lower blood sugar levels and protects the heart and kidneys.

What are the main side effects of Farxiga?

Common side effects include increased urination, urinary tract infections (UTIs), and mild dehydration. Serious side effects like diabetic ketoacidosis (DKA) or kidney problems are rare but possible.

Is there a generic version of Farxiga?

Currently, there is no generic version of Farxiga (dapagliflozin) available due to ongoing patent protection.

Can Farxiga be taken with other diabetes medications?

Yes, Farxiga is often combined with other diabetes medications, like metformin or insulin. However, combining these drugs can increase the risk of low blood sugar, so your doctor may adjust your dose.

How much does Farxiga cost without insurance?

Farxiga can cost around $500–$600 for a monthly supply without insurance. Prices may vary based on pharmacy location and discount programs.

[signup]

Key Takeaways

  • Farxiga (dapagliflozin) is an SGLT2 inhibitor approved to manage Type 2 diabetes, chronic kidney disease, and certain types of heart failure, helping lower blood sugar and protect heart and kidney function.
  • Common side effects include increased urination, urinary tract infections, yeast infections, and mild dehydration, while rare but serious risks include diabetic ketoacidosis (DKA) and kidney issues.
  • Farxiga interacts with medications like diuretics and insulin, and it is contraindicated for Type 1 diabetes, severe kidney disease, and during pregnancy or breastfeeding.
  • To use Farxiga safely, patients should stay hydrated, monitor for side effects, and follow dosage guidelines tailored to their specific condition.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Albarrán, O. G., & Ampudia-Blasco, F. J. (2013). Dapagliflozina, el primer inhibidor SGLT 2 en el tratamiento de la diabetes tipo 2. Medicina Clínica, 141, 36–43. https://doi.org/10.1016/s0025-7753(13)70062-9

Anderson, S. (2022, September 14). This is What Happens to Your Body When You are Dehydrated. Rupa Health. https://www.rupahealth.com/post/this-is-what-happens-to-your-body-when-you-are-dehydrated

Bryant, A. (2024a, October 18). Top 10 Lab Tests for Patients with Frequent Urination (Polyuria). Rupa Health. https://www.rupahealth.com/post/top-10-lab-tests-for-patients-with-frequent-urination-polyuria

Bryant, A. (2024b, October 25). Lab Tests for Patients with Dry Mouth and Eyes. Rupa Health. https://www.rupahealth.com/post/lab-tests-for-patients-with-dry-mouth-and-eyes

Cada, D. J., Levien, T. L., & Baker, D. E. (2014). Dapagliflozin. Hospital Pharmacy, 49(7), 647–662. https://doi.org/10.1310/hpj4907-647

CDC. (2024, May 9). About Diabetic Ketoacidosis. Diabetes. https://www.cdc.gov/diabetes/about/diabetic-ketoacidosis.html

Cloyd, J. (2023a, March 29). Top 5 Differential Diagnosis for Abdominal Pain and How to Treat With Functional Medicine. Rupa Health. https://www.rupahealth.com/post/top-5-differential-diagnoses-for-abdominal-pain-and-how-to-treat-with-functional-medicine

Cloyd, J. (2023b, June 14). A Complementary and Integrative Medicine Approach to Reoccurring UTI’s: Specialty Testing, Supplements, and Nutrition Options. Rupa Health. https://www.rupahealth.com/post/a-complementary-and-integrative-med-approach-to-reoccurring-utis-testing-supplements-and-nutrition-options

Cloyd, J. (2023c, July 13). A Functional Medicine UTI Protocol: Specialized Testing, Therapeutic Diet, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-uti-protocol-specialized-testing-therapeutic-diet-and-supplements

Cloyd, J. (2023d, September 15). Top Labs To Run Bi-Annually On Your Patients Who Suffer From Kidney Disease. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-kidney-disease

Cloyd, J. (2023e, September 28). Integrative medicine approach to treating hypotension. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-approach-to-treating-hypotension

Cloyd, J. (2024, January 8). The Science of Hydration: How Water Intake Affects Overall Health. Rupa Health. https://www.rupahealth.com/post/the-science-of-hydration-how-water-intake-affects-overall-health

Cox, A. D. (2022, September 8). 4 Herbs And Supplements That May Help Control Type 1 Diabetes. Rupa Health. https://www.rupahealth.com/post/a-root-cause-approach-to-managing-type-1-diabetes

Dapagliflozin. (2023, September 15). Nih.gov; National Institute of Child Health and Human Development. https://www.ncbi.nlm.nih.gov/books/NBK500971/

Davis, K. N., Hines, A., Schaefer, M. C., & Naseman, K. (2022). Protecting the Kidneys: Update on Therapies to Treat Diabetic Nephropathy. Clinical Diabetes, 40(3). https://doi.org/10.2337/cd21-0090

Dhillon, S. (2019). Dapagliflozin: A Review in Type 2 Diabetes. Drugs, 79(10), 1135–1146. https://doi.org/10.1007/s40265-019-01148-3

Easthope, A. (2022, May 26). 3 Ways To Treat Yeast Infections Without Medication. Rupa Health. https://www.rupahealth.com/post/natural-remedies-for-yeast-infections

FDA. (n.d.). HIGHLIGHTS OF PRESCRIBING INFORMATION. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202293s018lbl.pdf

FDA Approves Treatment for Chronic Kidney Disease. (2021, April 30). FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-treatment-chronic-kidney-disease

Goyal, A., Cusick, A. S., & Thielemier, B. (2023, June 26). ACE Inhibitors. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430896/

Herman, L. L., & Bashir, K. (2021). Hydrochlorothiazide. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/28613517/

Khan, T. M., Patel, R., & Siddiqui, A. H. (2021). Furosemide. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29763096/

Maholy, N. (2023, May 26). Integrative Nutrition Approaches to Managing Blood Sugar Levels. Rupa Health. https://www.rupahealth.com/post/integrative-nutrition-approaches-to-managing-blood-sugar-levels

Nashar, K., & Khalil, P. (2022). Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives. International Journal of Nephrology and Renovascular Disease, 15, 289–308. https://doi.org/10.2147/IJNRD.S234282

Padda, I. S., Mahtani, A. U., & Parmar, M. (2023, June 3). Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK576405/

Sizar, O., Podder, V., & Talati, R. (2023, May 29). Empagliflozin. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532925/

Stanford, J. (2024, June 20). NSAIDs Fact Sheet: Uses, Benefits, Risks, and More. Rupa Health. https://www.rupahealth.com/post/nsaids-fact-sheet

Sweetnich, J. (2023, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management

Thwaini, A. (2006). Fournier’s gangrene and its emergency management. Postgraduate Medical Journal, 82(970), 516–519. https://doi.org/10.1136/pgmj.2005.042069

Weinberg, J. (2023, February 21). 5 Lab Test To Run on Your Hypoglycemia Patients. Rupa Health. https://www.rupahealth.com/post/5-lab-test-for-your-hypoglycemia-patients

Yoshimura, H. (2024, May 31). Exercise Protocols for Cardiac Rehabilitation and Heart Failure. Rupa Health. https://www.rupahealth.com/post/exercise-protocols-for-cardiac-rehabilitation-and-heart-failure

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.